Phase 2 Type 2 Diabetes Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 to 70 years old at the time of signing the consent form, of any sex.
- People with a documented diagnosis of type 2 diabetes for at least 6 months before the screening visit, diagnosed according to Chinese diabetes guidelines (2024 Edition).
- People whose HbA1c (a measure of average blood sugar over time) was between 7.5% and 10.5% at the screening visit.
- People who have been managing their diabetes with lifestyle changes alone for at least 8 weeks, or with a stable dose of metformin alone for at least 8 weeks, before screening — with no changes to that treatment planned during the trial.
- People whose fasting blood sugar level was no higher than 15 mmol/L.
- People with a body mass index (BMI) between 20.0 and 40.0 kg/m² at screening.
- People who are willing and able to follow the trial procedures, fully understand what the trial involves, and sign a consent form before the trial begins.
- People who have no plans to become pregnant from the time of signing the consent form until at least 2 months after the last dose, and who agree to use highly effective contraception as specified by the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with certain abnormal test results at screening (confirm with trial site).
- People with clinically significant abnormal heart readings on an ECG that the investigator considers a safety concern.
- People with poorly controlled blood pressure.
- People diagnosed with or suspected of having type 1 diabetes, a specific type of diabetes, or diabetes caused by another condition.
- People who had a serious sudden diabetes-related complication in the 6 months before screening.
- People who had a severe low blood sugar episode, or repeated low blood sugar episodes, in the 6 months before screening.
- People with serious long-term diabetes complications at screening, or a type of eye condition related to diabetes that would require treatment during the trial.
- People with a personal or family history of a specific type of thyroid cancer (medullary thyroid carcinoma) or a related inherited condition called multiple endocrine neoplasia syndrome type 2.
- People with a past or known history of pancreas inflammation, pancreatic injury, acute gallbladder inflammation, or gallbladder disease requiring treatment.
- People with a history of significant digestive tract conditions (such as severe stomach-emptying problems, bowel obstruction, inflammatory bowel disease, or active ulcers), or who have had certain gastrointestinal surgeries, or who regularly take medications that affect how the digestive tract moves.
- People who had a serious heart or stroke-related event in the 6 months before screening.
- People with a known or suspected history of depression, bipolar disorder, suicidal thoughts, schizophrenia, or other serious mental health conditions; or people who are unable to fully understand the trial or are unwilling to work with the trial team.
- People who have had a malignant (cancerous) tumour in the 5 years before screening, except for certain fully treated localised cancers such as basal cell skin cancer, cervical carcinoma in situ, or prostate carcinoma in situ.
- People who are pregnant, breastfeeding, or planning to become pregnant during the trial.
- People whom the investigator considers unsuitable for the trial for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
If you need support right now
This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.
If you or someone else is in immediate danger, call 000.
- Lifeline — 24/7 crisis support: 13 11 14
- Suicide Call Back Service — 24/7 counselling: 1300 659 467
- 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
- Beyond Blue — 24/7 mental health support: 1300 22 4636
- Emergency: 000
Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.
Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.
Contact this trial
Phone: 17721288226
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in glycated hemoglobin (HbA1c) relative to baseline
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.